PT  - JOURNAL ARTICLE
ED  - Wilke, William S.
AU  - Jonathan Kay
TI  - Beta<sub>2</sub>-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
DP  - 1999 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 145--147
VI  - 66
IP  - 3
4099  - http://www.ccjm.org/content/66/3/145.short
4100  - http://www.ccjm.org/content/66/3/145.full
SO  - Cleve Clin J Med1999 Mar 01; 66
AB  - Beta2-microglobulin amyloidosis can cause significant suffering in patients with chronic renal failure. Although renal transplantation is currently the only treatment, medical and surgical therapies may decrease pain and disability.